During an abdominal surgery, if an MH crisis is suspected, what should the surgical technologist do?

In the event of a suspected malignant hyperthermia (MH) crisis during abdominal surgery, the surgical technologist should prioritize the safety of the patient by preparing to close the surgical site quickly. Malignant hyperthermia is a serious reaction to certain anesthesia agents, leading to a rapid increase in metabolic rate, body temperature, and muscle rigidity. If such a crisis is suspected, the surgical team needs to respond immediately to minimize complications and stabilize the patient's condition.

One of the crucial elements in managing an MH crisis is to ensure that the surgical procedure does not prolong the patient's exposure to potentially hazardous conditions. Rapid closure of the surgical site allows for immediate intervention and supportive measures, such as administering dantrolene, which is the antidote for malignant hyperthermia, and cooling the patient.

While notifying the anesthetist is also a critical step, the choice emphasizes the need for prompt action by preparing to close, which directly impacts the patient's safety and management of the crisis. Other responses, like continuing with the procedure or calling for additional personnel, may further delay the necessary response to the crisis at hand.